drugset / Trial / NCT00469690
Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients: Trough Drug Effects
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to compare the ability of two different topical NSAIDs (non-steroidal anti-inflammatory medications used for pain relief) to reach the back of the eye and to stop inflammation. The study will conclude on the day of your cataract surgery.
Timeline
- Start
- 2007-05
- Primary completion
- 2008-05
- Completion
- 2008-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bromfenac | Other / unclassified | 5 ml | Other |
| Subject | Ketorolac Tromethamine | Small molecule | 5 ml | Other |